From somatic mutations to Quotient

2024-07-05T10:10:12+01:0021 November 2023|

We spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.

Four Institute researchers have made it to Reuters most influential list

2012-06-21T13:29:41+01:0021 June 2012|

Four of the Wellcome Trust Sanger Institute researchers been cited by Thomson Reuters as being among the top 15 most influential scientific researchers of 2011. Professor Mike Stratton, Dr Andy Futreal, Dr Peter Campbell and Dr Panos Deloukas, according to citations tracked during 2011, recorded some of the highest numbers of “Hot Papers” published over the preceding two years.